Skip to content

Owlet OWLT Purchase Obligation

Discontinued — last reported Q4 '20

Purchase Obligation at other companies

iRadimed logo
iRadimedIRMD

Other financials

Income statement

See full
Revenue$22.5M+6.4%
Gross profit$12.2M+8.1%
Operating income-$5.5M-106%
Net income-$3.3M-210%
EPS (diluted)-$0.25-327%

Balance sheet

See full
Cash & equivalents$41.0M+147%
Total debt$35.6M+48.6%
Total equity$21.0M+181%
Total assets$86.8M+68.8%

Cash flow

See full
Operating cash flow-$5.0M+14.8%
CapEx$15.0K+275%
Free cash flow-$5.1M+14.6%

Valuation

See full
Market cap$166.47M+30.3%
Enterprise value$161.04M+12.4%
P/S1.6×+0.1×

Profitability

See full
Gross margin50.9%-1.4pp
Operating margin-10.4%-3.4pp
Net margin-43%-94.2pp
FCF margin-9.5%

Returns & leverage

See full
Return on equity-206.1%
Debt / equity1.7×
Current ratio1.7×+0.5×

Where this comes from

Reported directly by Owlet in its filing.

Tagged under the XBRL concept us-gaap:ContractualObligation.

The official record: Owlet’s 10-K, filed March 25, 2021, on SEC EDGAR. View the filing →